A Phase 3, Multi-centric, Single blind, Randomized, Comparative study to assess the efficacy and safety of fixed dose combination of Telmisartan + Amlodipine + Hydrochlorothiazide bi-layered tablet verses Telmisartan + Hydrochlorothiazide tablet for the treatment in patients with essential hypertension.
Phase of Trial: Phase III
Latest Information Update: 02 Sep 2016
At a glance
- Drugs Amlodipine/telmisartan/hydrochlorothiazide (Primary) ; Telmisartan/hydrochlorothiazide
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Aristo Pharmaceuticals
- 10 Jun 2013 Status changed from recruiting to completed as reported by Clinical Trials Registry - India record.
- 05 Jun 2010 New trial record